Get comprehensive analysis of Novo Nordisk A/S (NVO) stock with our professional-grade research platform. Our analysis combines DCF valuation models with AI-powered predictions to give you the complete picture.
Novo Nordisk A/S is a Healthcare company with a market capitalization of $210.86 billion. Currently trading at $47.42, the stock is down 2.13% today.
Novo Nordisk A/S (NVO) represents a significant investment opportunity in the Healthcare sector. Understanding the company's financial health, valuation metrics, and growth prospects is essential for making informed investment decisions.
Our analysis provides institutional-grade research typically reserved for professional investors, now available for free. We update NVO data daily to ensure you have the most current information for your investment decisions.